Johnson BE - Search Results

1

Brunner AM, Costa DB, Heist RS, Garcia E, Lindeman NI, Sholl LM, Oxnard GR, Johnson BE, Hammerman PS. Brunner AM, et al. Among authors: johnson be. J Thorac Oncol. 2013 Nov;8(11):1434-7. doi: 10.1097/JTO.0b013e3182a47162. J Thorac Oncol. 2013. PMID: 24128713 Free PMC article. Clinical Trial.

2

Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation.

Johnson BE, Grayson J, Makuch RW, Linnoila RI, Anderson MJ, Cohen MH, Glatstein E, Minna JD, Ihde DC. Johnson BE, et al. J Clin Oncol. 1990 Mar;8(3):396-401. doi: 10.1200/JCO.1990.8.3.396. J Clin Oncol. 1990. PMID: 2155310

3

The development of small cell lung cancer in the contralateral lung of a patient surviving 8 years after the original diagnosis of small cell lung cancer.

Howard JR Jr, Veach SR, DeVaney K, Walsh T, Cotelingam JD, Johnson BE. Howard JR Jr, et al. Among authors: johnson be. Cancer. 1988 Jul 15;62(2):436-9. doi: 10.1002/1097-0142(19880715)62:2<436::aid-cncr2820620231>3.0.co;2-9. Cancer. 1988. PMID: 2838153

4

Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer.

Georgiadis MS, Schuler BS, Brown JE, Kieffer LV, Steinberg SM, Wilson WH, Takimoto CH, Kelley MJ, Johnson BE. Georgiadis MS, et al. Among authors: johnson be. J Clin Oncol. 1997 Feb;15(2):735-43. doi: 10.1200/JCO.1997.15.2.735. J Clin Oncol. 1997. PMID: 9053499 Clinical Trial.

5

Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancer.

Kasturi VK, Dearing MP, Piscitelli SC, Russell EK, Sladek GG, O'Neil K, Turner GA, Morton TL, Christian MC, Johnson BE, Kelley MJ. Kasturi VK, et al. Among authors: johnson be. Clin Cancer Res. 1998 Sep;4(9):2095-102. Clin Cancer Res. 1998. PMID: 9748125 Clinical Trial.

6

Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.

Cortazar P, Gazdar AF, Woods E, Russell E, Steinberg SM, Williams J, Ihde DC, Johnson BE. Cortazar P, et al. Among authors: johnson be. Clin Cancer Res. 1997 May;3(5):741-7. Clin Cancer Res. 1997. PMID: 9815744 Clinical Trial.

7

Genetic analysis of second primary lung cancers in patients surviving small cell lung cancer.

Kelley MJ, Nakagawa K, Conrad NK, LeRiche J, Murray N, Lee JS, Ro JY, Shaw EG, Tucker MA, Johnson BE. Kelley MJ, et al. Among authors: johnson be. Clin Cancer Res. 1996 Jul;2(7):1103-5. Clin Cancer Res. 1996. PMID: 9816274

8

Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress.

Chute JP, Chen T, Feigal E, Simon R, Johnson BE. Chute JP, et al. Among authors: johnson be. J Clin Oncol. 1999 Jun;17(6):1794-801. doi: 10.1200/JCO.1999.17.6.1794. J Clin Oncol. 1999. PMID: 10561217

9

Lung cancer presenting with solitary bone metastases. Case 2: acrometastasis as an initial presentation of non-small-cell lung carcinoma.

Jänne PA, Datta MW, Johnson BE. Jänne PA, et al. Among authors: johnson be. J Clin Oncol. 1999 Sep;17(9):2998-3001. doi: 10.1200/JCO.1999.17.9.2998. J Clin Oncol. 1999. PMID: 10561378 No abstract available.

10

Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.

Breathnach OS, Georgiadis MS, Schuler BS, Pizzella P, Llorens V, Kasturi V, Steinberg SM, O'Neil K, Takimoto CH, Johnson BE. Breathnach OS, et al. Among authors: johnson be. Clin Cancer Res. 2000 Jul;6(7):2670-6. Clin Cancer Res. 2000. PMID: 10914708 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters